NEWSROOM

Biotech

BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference

BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference

Mar 31, 2026

POMPANO BEACH, Fla., March 31, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the 25th Annual Needham Virtual Healthcare Conference. BioStem’s management is scheduled to present on Monday, April 13, 2026, at 8:45 am ET....

BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference

BioStem Technologies Announces the Publication of its Audited Financial Statements for Fiscal Years 2024 and 2025

Mar 30, 2026

The Company continues its progression towards a Nasdaq uplisting POMPANO BEACH, FL, March 30, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that it has filed its audited consolidated financial statements as of and for the fiscal years ended December 31, 2024 and...

BioStem Technologies to Present at the 25th Annual Needham Virtual Healthcare Conference

BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial Results

Mar 24, 2026

Strategic acquisition and strong margins help offset market pressures and position BioStem for renewed growth in 2026 POMPANO BEACH, FL, March 24, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today reported financial results for the fourth quarter and full year ended December 31,...

ProText Mobility Inc. (OTC: TXTM) Updates Shareholders on Strategic Developments, Liquidity, and Stock Purchases

ProText Mobility Inc. (OTC: TXTM) Updates Shareholders on Strategic Developments, Liquidity, and Stock Purchases

Mar 13, 2026

Key Highlights Ongoing open-ended discretionary stock purchases by the president and chairman, demonstrating confidence in TXTM’s growth and future. No salaries paid from inception to date, ensuring financial discipline and no dilution. The company has not had any reverse stock splits to date, protecting value for shareholders. Strategic liquidity arrangements with BNY Mellon, Standard Bank, Absa, and Melville Douglas. Custodial wallet pilot program supporting foreign direct trade and the...

BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026

BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026

Mar 11, 2026

Conference call and webcast to be held at 4:30 PM ET POMPANO BEACH, Fla., March 11, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products for regenerative medicine, today announces it will release its fourth quarter and full year 2025 financial results on Tuesday, March 24, 2026, and will host a...

BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026

BioStem Technologies Highlights Alignment with FDA’s Openness to Bayesian Statistical Approaches in Clinical Research

Feb 3, 2026

POMPANO BEACH, Fla., February 3, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of perinatal tissue derived products for advanced wound care, today underscored the significance of recent remarks from U.S. Food and Drug Administration (FDA) leadership signaling openness to expanded use of Bayesian statistical methodologies in clinical...

Protext Mobility, Inc. (OTC: TXTM) is thrilled to share a transformative update, advancing uplisting readiness with a preliminary Deloitte engagement

Protext Mobility, Inc. (OTC: TXTM) is thrilled to share a transformative update, advancing uplisting readiness with a preliminary Deloitte engagement

Jan 20, 2026

Protext Mobility taps Deloitte to assess enterprise value as uplisting and ESG monetization accelerate Fort Lauderdale, Florida, January 20, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Protext Mobility, Inc. (OTC: TXTM) (“Protext” “TXTM” or the “Company”) is thrilled to share a transformative update that underscores its strategic execution, operational excellence, ESG leadership, and forward momentum, reinforcing shareholder confidence and highlighting the...

Easy Environmental Solutions Enters 2026 With Accelerated Global Momentum and a Clear Path to Scale

Easy Environmental Solutions Enters 2026 With Accelerated Global Momentum and a Clear Path to Scale

Jan 8, 2026

Company surpasses 2025 international development targets and advances toward multi-continent deployment of disruptive integrated soil and water technologies Takeaways: Easy Environmental Solutions moves from pilot validation to global infrastructure-scale deployment in 2026. EasyFEN™, Terreplenish®, and NanoVoid™ form a unified, cost-efficient sustainability platform. Africa, the Middle East, and France anchor multi-continent growth and commercialization. Mankato, Minn., January 8th,...

BioStem Technologies to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on March 24, 2026

BioStem Technologies Comments on Withdrawal of CMS CY 2026 Final Medicare Reimbursement Rule for Skin Substitutes

Jan 7, 2026

Decision ensures continued patient access to VENDAJE® and VENDAJE AC® POMPANO BEACH, Fla., Jan. 07, 2026 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today commented on the withdrawal of all seven of the Centers for Medicare & Medicaid Services’ (“CMS”) Local Coverage...

Easy Environmental Solutions Announces New Distribution Partnership to Expand Access to Terreplenish®

Easy Environmental Solutions Announces New Distribution Partnership to Expand Access to Terreplenish®

Jan 5, 2026

New partnership accelerates Easy Environmental Solutions’ growth while bringing Terreplenish® regenerative soil technology to nearly 800 retail locations nationwide Takeways: Easy Environmental Solutions expands its national footprint through a new distribution partnership, accelerating access to regenerative soil technologies. Terreplenish® will reach nearly 800 retail locations, supporting growers and land managers with organic, biology-driven soil health solutions. Easy Environmental...

BioStem Technologies Expands Product Access in Medicaid

BioStem Technologies Expands Product Access in Medicaid

Nov 25, 2025

Florida Medicaid Adds BioStem’s VENDAJEⓇ and VENDAJE ACⓇ to Covered Skin Substitutes List Key Takeaways Major reimbursement milestone — Florida Medicaid now covers VENDAJE® and VENDAJE AC®, expanding BioStem’s reach to 13 Medicaid programs nationwide. Significant market expansion — Florida, one of the largest Medicaid states, meaningfully grows BioStem’s addressable patient population and validates its clinical and economic value. Growth catalyst for 2026 — Expanded coverage strengthens...

Easy Environmental Solutions Enters 2026 With Accelerated Global Momentum and a Clear Path to Scale

Easy Environmental Solutions Begins Trading Under New Ticker Symbol “EZES”

Nov 7, 2025

Company prepares for first Easy FEN™ system deployment in Africa as part of global expansion strategy Key Takeaways New Ticker Symbol Reflects Growth and RebrandEasy Environmental Solutions, formerly Digital Utilities Ventures, begins trading as EZES, signaling a new era focused on modular sustainability technologies. Global Expansion with Easy FEN™ Launch in AfricaThe company’s first Easy FEN™ system deployment is planned for early 2026, converting food waste into regenerative agricultural...

Nephros Announces Strong Third Quarter Financial Results; Achieving Highest Level of Programmatic Sales in Company History

Nephros Announces Strong Third Quarter Financial Results; Achieving Highest Level of Programmatic Sales in Company History

Nov 6, 2025

Third-Quarter Net Revenue of $4.8 million; Robust Growth Drives 35% Increase in Net Revenue and Fourth Consecutive Quarter of Profitability SOUTH ORANGE, NJ, November 6, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced financial results for the third quarter ended September 30, 2025. Financial Highlights Net...

BioStem Technologies Expands Product Access in Medicaid

BioStem Technologies Provides Comments on CMS CY 2026 Final Medicare Reimbursement Rule Changes for Skin Substitutes

Nov 5, 2025

Key Takeaways CMS’s final rule praised for transparency — BioStem welcomed the 2026 Medicare reimbursement reform for skin substitutes as a move toward a fair, predictable system rewarding proven outcomes. BioREtain® supports evidence-based care — The company’s BioREtain® allografts, validated in a Level 1 randomized trial showing superior outcomes, align with CMS’s push for clinically proven, cost-efficient products. Strong economics under new model — Vertically integrated GMP manufacturing...

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters

Nov 5, 2025

Future Relocation and Expansion to Create Up to 100 New Jobs Over 5 Years City Approves Up to $300,000 in Economic Incentives to Rapidly Growing MedTech Business POMPANO BEACH, Fla., Nov. 5, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced the purchase of land for...

Protext Mobility, Inc. (OTC: TXTM) Announces CEO Statement Following Removal of Caveat Emptor Designation

Protext Mobility, Inc. (OTC: TXTM) Announces CEO Statement Following Removal of Caveat Emptor Designation

Oct 31, 2025

Key Takeaways Caveat Emptor Removal Marks New Growth PhaseProtext Mobility, Inc. (OTC: TXTM) announced a renewed strategic focus following the removal of its Caveat Emptor designation, signaling restored market confidence. Leadership Alignment with ShareholdersPresident and Chairman Dylon Du Plooy confirmed that he has personally purchased more than 200 million TXTM shares in the open market since 2024, while the CEO’s preferred shares will remain unconverted, eliminating dilution risk. No...

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters

BioStem Technologies Appoints KPMG as its Independent Registered Public Accountant

Oct 27, 2025

POMPANO BEACH, FL, October 27, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM) (the “Company”), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, today announced that the Audit Committee of its Board of Directors has approved the appointment of KPMG LLP (“KPMG”) as the Company's independent registered public accounting firm, and it...

Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration

Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration

Oct 27, 2025

Protext Mobility to launch IR Presentation & MicrositeTXTM is rolling out a modern investor hub to elevate transparency and engagement, aligning communications with top-tier governance standards. Next-gen investor access in one placeThe hub centralizes real-time financials, filings, interactive charts, live press releases, investor webcasts, and email alerts—creating a single command center for shareholders. Governance first, clear timelineProtext is voluntarily EDGARizing disclosures and...

Halberd Corporation Successfully Demonstrates its Proprietary Breakthrough AI Technology for Behavioral Analysis Platform

Halberd Corporation Successfully Demonstrates its Proprietary Breakthrough AI Technology for Behavioral Analysis Platform

Oct 27, 2025

Live Technical Demonstration Validates NeuroSense AI Platform Feasibility; Development Moves Forward with Proven Core Technologies Halberd Demonstrates NeuroSense AI FeasibilityHalberd Corporation successfully validated its NeuroSense AI system in a live demonstration, showcasing advanced multi-modal behavioral analysis technology designed to revolutionize traumatic brain injury (TBI) research and neurological diagnostics. AI-Powered Insights into Brain and Behavioral FunctionThe NeuroSense AI...

Protext Mobility, Inc. (OTC: TXTM) Ignites Next Phase of Growth with Investor Relations Presentation Initiative — Setting the Stage for a New Era of Transparency and Acceleration

Protext Mobility, Inc. (OTC: TXTM) Announces Plans for Corporate Website Redesign and Investor Relations Suite to Enhance Transparency and Shareholder Engagement

Oct 17, 2025

NEW YORK, Oct. 17, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Protext Mobility, Inc. (OTC: TXTM), an emerging leader in botanical-based biotechnology, today announced its strategic initiative to redesign its corporate website and develop a dedicated Investor Relations (IR) Suite, as part of the company’s commitment to transparency, regulatory compliance, and proactive investor communication. This planned digital transformation reflects Protext’s mission to...

Easy Environmental Solutions Announces New Distribution Partnership to Expand Access to Terreplenish®

Digital Utilities Ventures Completes Acquisition and Name Change

Oct 9, 2025

Planned uplist to OTCQB Venture Exchange, if approved will follow completion of audit and previously announced reverse split Mankato, Minn., October 9, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Digital Utilities Ventures, Inc. (OTC: DUTV), operating as Easy Environmental Solutions, has received notice that the processing of its corporate action by FINRA has been completed. As a result, the Company finalizes its acquisition of Lifestyle Dock Company,...

Nephros Launches New PFAS Filter for Point-of-Use Protection of Potable Water

Nephros Launches New PFAS Filter for Point-of-Use Protection of Potable Water

Oct 8, 2025

New 19-Series solution targets wide range of chemical contaminants SOUTH ORANGE, NJ, October 8, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to medical and commercial markets, today announced the launch of its new filter designed to reduce Total PFAS, or per- and polyfluoroalkyl substances (PFAS), in potable water. This product expands Nephros’ portfolio to address a...

California Governor Newsom Signs AB30 Approving 15% Ethanol Blend that Increases Ethanol Market by more than 600 million Gallons Per Year

California Governor Newsom Signs AB30 Approving 15% Ethanol Blend that Increases Ethanol Market by more than 600 million Gallons Per Year

Oct 3, 2025

CUPERTINO, Calif., October 3, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and biofuels company, announced today that California Governor Gavin Newsom signed Assembly Bill 30 (AB30), which immediately allows 15% ethanol blending in gasoline and expands the potential California market for ethanol by 50% by increasing from an E10 to E15 blend. According to a study by UC Berkeley/Naval Academy, a 15% ethanol...

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters

BioStem Technologies Expands Partnership with the Florida Panthers as a Sponsor for the 13th Season of the “Heroes Among Us” Program

Oct 2, 2025

Program has honored more than 500 members of the military since its inception Sponsorship honors both local military veterans and healthcare professionals POMPANO BEACH, Fla., October 2, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, and the Florida Panthers, announced today that...

Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT

Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT

Sep 25, 2025

LAS VEGAS, Sept. 25, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced that its MyCardia AT device has been issued a Medical Device License (MDL) by Health Canada and is now approved for import into Canada, effective immediately. The device, rebranded as the CardioHolter AT, will be...

Cardiac Biotech Solutions, Inc. Secures Health Canada License for MyCardia AT Device, Now Branded as CardioHolter AT

Cardiac Biotech Solutions, Inc. (CBSC) Signs Exclusive 5-Year Distribution Agreement with Noventis Medical Covering Costa Rica, Panama, Colombia, and Argentina

Sep 4, 2025

LAS VEGAS, Sept. 04, 2025 - PRISM MediaWire (Press Release Service - Press Release Distribution) - Cardiac Biotech Solutions, Inc. (OTCID: CBSC) ("CBSC" or the "Company"), a designer, manufacturer, and distributor of non-invasive ambulatory cardiac monitoring products, today announced the execution of a new distribution agreement with Noventis Medical, granting the Company five-year exclusive rights to distribute CBSC’s products across Costa Rica, Panama, Colombia, and Argentina. Under the...

BioStem Technologies Secures Land Purchase at the Research Park at Florida Atlantic University in Boca Raton for Future Headquarters

BioStem Technologies Announces Insider Share Purchase by Chairman and Chief Executive Officer

Aug 21, 2025

POMPANO BEACH, FL, August 21, 2025 - PRISM MediaWire - BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and commercialization of placental-derived products for advanced wound care, discloses an insider purchase of common stock from Jason Matuszewski, Chairman and Chief Executive Officer of BioStem Technologies. Mr. Matuszewski purchased a total of 15,500 shares on August 19, 2025, totaling approximately $100,000. The purchases were...

Nephros Announces Strong Third Quarter Financial Results; Achieving Highest Level of Programmatic Sales in Company History

Nephros Schedules Second Quarter 2025 Financial Results Conference Call

Jul 31, 2025

SOUTH ORANGE, N.J., July 31, 2025 - PRISM MediaWire - Nephros, Inc. (Nasdaq: NEPH), a leading water technology company providing filtration solutions to the medical and commercial markets, today announced that it will file its second-quarter financial results on Thursday, August 07, 2025, after market close and will host a conference call that same day at 4:30 pm ET. Participants may dial into the call as follows:Domestic access: 1 (844) 808-7106International access: 1 (412) 317-5285 Upon...

Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates

Protagenic Therapeutics Announces Grant of new patent in Japan for its Modified Stilbenoid Program Drug Candidates

Jul 30, 2025

NEW YORK, NY and SANTA BARBARA, CA, July 30, 2025 - PRISM MediaWire - Protagenic Therapeutics, Inc. (Nasdaq: PTIX) (the “Company”) today announces that on July 18, 2025, the Japanese Patent Office granted Patent JP 7714571B, a patent which runs until March 31, 2041. This patent underpins one of the Company’s key pipeline assets, a modified stilbenoid, and importantly provides the Company with exclusivity to particular compounds per se, formulations containing a number of drug candidates, and...

THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery

THC Therapeutics, Inc. Announces Acquisition of SugarTop Buddery

Jul 9, 2025

Ten-Year Legacy Brand Joins THCT Portfolio, Expanding National Craft Cannabis Footprint and Female-Founded Leadership Medford, OR, July 8, 2025 - PRISM MediaWire - THC Therapeutics, Inc. (“THCT” or the “Company”), (OTC: THCT), a company focused on the legal and regulated cannabis industry, is proud to announce the acquisition of all issued and outstanding membership interests of STHoldings Group LLC, the parent company of iconic Eugene, Oregon cannabis brand SugarTop Buddery, in an all-share...